1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Analysis & Statistics in France, May 2019

Cancer Analysis & Statistics in France, May 2019

1-30 of about 200 reports

2019 France Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

2019 France Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • Industry report
  • April 2019

2019 France Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for SuppliersHighlightsComprehensive 585-page ...

  • Industries : Cancer
  • Countries : France
Hybrigenics SA (ALHYG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hybrigenics SA (ALHYG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryHybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases.Its lead product candidate Inecalcitol, is a ...

  • Industries : Pharmaceutical, Medical Biotechnology
  • Countries : France
Curie Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Curie Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryCurie Institute is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer.The foundation carries out research ...

  • Industries : Health Services
  • Countries : France
OSE Immunotherapeutics (OSE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

OSE Immunotherapeutics (OSE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryOSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers.The company’s ...

  • Industries : Medical Biotechnology, Pharmaceutical
  • Countries : France
Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryTransgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases.The ...

  • Industries : Medical Biotechnology, Therapy, Pharmaceutical
  • Countries : United States, France
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • $ 7995
  • Industry report
  • September 2018

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EUSummaryMarket access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, more ...

  • Industries : Pharmaceutical, Therapy, Oncology, Healthcare
  • Countries : United Kingdom, Italy, Germany, Western Europe, France, Europe, Southern Europe, Spain
IntegraGen SA (ALINT) - Product Pipeline Analysis, 2018 Update

IntegraGen SA (ALINT) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • July 2018

SummaryIntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology.The company provides advanced genomic and bioinformatic services, ...

  • Industries : Diagnostics
  • Countries : United States, France
Nanobiotix SA (NANO) - Product Pipeline Analysis, 2018 Update

Nanobiotix SA (NANO) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • May 2018

SummaryNanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers.The company develops first-in-class products utilizing its proprietary technology ...

  • Industries : Cancer, Pathology
  • Countries : United States, France
Institut Curie - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Institut Curie - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2017

SummaryInstitut Curie is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research ...

  • Industries : Health Services
  • Countries : France
EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2025

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2025

  • $ 3995
  • Industry report
  • November 2017

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2025SummaryChronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is a type of cancer of the white blood cells ...

  • Industries : Cancer
  • Countries : United States, Canada, Italy, Germany, France, North America, Spain
Europe Pediatric Proton Therapy Market & Forecast (6 Countries Market Data), Patients Treated, Reimbursement Policies

Europe Pediatric Proton Therapy Market & Forecast (6 Countries Market Data), Patients Treated, Reimbursement Policies

  • $ 1600
  • Industry report
  • July 2017

Europe Pediatric Proton Therapy Market has a market potential close to US$ 150 Million by 2022. The rise of pediatric cancer incidence in Europe region and proton therapy gaining prominence and credibility ...

  • Industries : Cancer
  • Countries : World, Western Europe, United Kingdom, Europe, Northern Europe, Germany, Czech Republic, Switzerland, Sweden, France
France Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

France Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

  • $ 1050
  • Industry report
  • May 2017

France represents a huge untapped market opportunity for proton therapy.Proton therapy is an advanced treatment of tumors which minimizes the risks and increases the chances of the oncology patient, ensuring ...

  • Industries : Diagnostic Imaging
  • Countries : France
Europe Proton Therapy Market & Forecast, Patients Treated at Proton Therapy Centers, Reimbursement Policy

Europe Proton Therapy Market & Forecast, Patients Treated at Proton Therapy Centers, Reimbursement Policy

  • $ 1700
  • Industry report
  • April 2017

Europe Proton Therapy Market has a market potential of much more than US$ 10 Billion in 2016. In the year 2009 France used be have the highest proton therapy market share. But by 2012 Germany replaced ...

  • Industries : Health Services
  • Countries : Western Europe, Northern Europe, Germany, Europe, Eastern Europe, Sweden, United Kingdom, World, Switzerland, Italy, Russia, France, Poland, Scandinavia
Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2017

Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Prostate Cancer patients study in a new report ‘Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Prostate ...

  • Industries : Cancer, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Ovarian Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Ovarian Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Ovarian Cancer patients study in a new report ‘Europe Ovarian Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Ovarian ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017

Europe Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Acute Myeloid Leukemia patients study in a new report ‘Europe Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Small Cell Lung Cancer patients study in a new report ‘Europe Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017

Europe Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Chronic Myeloid Leukemia patients study in a new report ‘Europe Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017’. The report provides ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Gastric Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Gastric Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Gastric Cancer patients study in a new report ‘Europe Gastric Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Gastric ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Brain Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Brain Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Brain Cancer patients study in a new report ‘Europe Brain Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Brain Cance ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017

Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Non-Hodgkins Lymphoma patients study in a new report ‘Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Cancer, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017

Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Gastrointestinal Stromal Tumor patients study in a new report ‘Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017’. The report ...

  • Industries : Cancer, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Bladder Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Bladder Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bladder Cancer patients study in a new report ‘Europe Bladder Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Bladde ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017

Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Multiple Myeloma patients study in a new report ‘Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Multiple ...

  • Industries : Cancer, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017

Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Gastric Cancer patients study in a new report ‘Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Gastric ...

  • Industries : Cancer, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Cervical Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Cervical Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Cervical Cancer patients study in a new report ‘Europe Cervical Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Cervical ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017

Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Renal Cell Carcinoma patients study in a new report ‘Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Cancer, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017

Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Pancreatic Cancer patients study in a new report ‘Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Cancer, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2017

Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Cervical Cancer patients study in a new report ‘Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Cervical ...

  • Industries : Cancer, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2017

Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bladder Cancer patients study in a new report ‘Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Bladde ...

  • Industries : Cancer, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on